|
FASEB Updates
By the FASEB Office of Public Affairs Staff: Jennifer Hobin, Director of Science Policy;
Jennifer Zeitzer, Director of Legislative Relations; Tyrone Spady, Science Policy Analyst;
Ann Deschamps, Science Policy Analyst

Since 2003 ISCB has been a member society of the Federation of
American Societies for Experimental Biology (FASEB;
www.faseb.org),
primarily for the high level advocacy that FASEB engages in with the
U.S. government. This gives a voice to ISCB in issues related to
science policy and funding that impacts scientists in the U.S. and
around the globe. The following is an overview of the science policy
initiatives FASEB has led on behalf of the biomedical research
community during the last year.
FY 2011 - FY 2012 Budget
Update Although President Obama proposed a significant increase in
funding for the U.S. National Institutes of Health (NIH) and other
science agencies, Congress's attention was focused on cutting
billions in federal spending. These cuts would have had global
ramifications, as students and postdocs from all over the world
conduct their training in the U.S. Without consistently strong U.S.
government support for research, these opportunities for cross
cultural collaboration and exchange could dry up.
FASEB
mounted a concerted advocacy campaign to prevent these cuts, sending
letters from President William Talman, MD, to key legislative
committees, issuing e-action alerts that generated thousands of
emails and phone calls to lawmakers, and organizing a Capitol Hill
Day attended by ISCB member Dr. Judith Blake. Success was achieved
in April when Congress passed the final fiscal year (FY) 2011 budget
without any major cuts in funding for the U.S. science agencies.
Policymakers have now turned their attention to the FY 2012 budget.
Once again, President Obama is seeking increased funding for NIH
while Congress is considering significant cuts. FASEB will continue
to press lawmakers to sustain funding for biomedical science.
Research Information Technology and Infrastructure With
information technology playing an increasingly prominent role in
research, FASEB has been working to educate policymakers on the
opportunities associated with adoption of electronic health records
(EHR) and the development of a national health information
infrastructure. Under the leadership of ISCB member Dr. John Wooley,
FASEB developed several policy statements arguing that EHR data will
be important not just to clinicians, but also to scientists working
to improve human health. This message has been taken to the White
House Office of Science and Technology Policy, the President's
Council of Advisors on Science and Technology, and the Centers for
Medicare and Medicaid Services.
Science Training In addition
to advocating for science funding, FASEB has been working to shape
research training policy. We endorsed many of the recommendations
made in the National Research Council's Research Training in the
Biomedical, Behavioral, and Clinical Research Sciences report,
testified before an NIH task force charged with developing a model
for a sustainable and diverse science workforce, and promoted
policies incorporated into the National Institute of General Medical
Sciences (NIGMS) strategic plan for training and career development.
Specifically, FASEB has urged policy makers to facilitate training
for a broad range of scientific careers, promote the creation of
training plans by faculty mentors, and encourage trainees to develop
individual career and professional development plans. FASEB
continues to mobilize efforts to ensure that we maintain the
quality of research training in the U.S.
Animals in Research
and Education FASEB is a strong proponent of the humane use of
animals in research. We recently embarked on an international effort
to help research institutions address the threat of animal rights
extremism, and we are preparing comments on the International
Guiding Principles for Biomedical Research Involving Animals. The
principles provide a conceptual and ethical framework for countries
using vertebrate animals in research. FASEB has also been leading an
effort to defeat legislation pending in the U.S. Congress that would
prohibit research on great apes, including chimpanzees. If adopted,
the Great Ape Protection and Cost Savings Act of 2011 could have a
global impact as pharmaceutical companies based outside the U.S.
frequently use U.S.-owned chimpanzees to test the safety of new
compounds.
Service to ISCB Sudent and Minority Members FASEB
administers two multi-year NIGMS/NIH Minority Access to Research
Careers (MARC) grants to help U.S. citizens and permanent resident
underrepresented minority students with the costs of attending
conferences, including any official meeting of ISCB. The FASEB MARC
Program provided ISCB student and post doc members with full travel
and registration costs to attend ISMB 2010 in Boston (7 supported),
Rocky 2010 in Colorado (2 supported), ISCB Latin America 2010 in
Uruguay (1 supported), and GLBIO 2011 in Ohio (1 supported). For
ISMB/ECCB 2011 in Vienna FASEB has confirmed travel and registration
support for 6 ISCB students and post docs. FASEB MARC also sponsored
the Student Council booth space at ISMBs in 2008, 2009, and 2010,
including the travel, registration, and fees for participation by an
expert who provided CV critiques for trainees seeking career advice.
For the past three years, FASEB has sponsored ISCB's booth and
travel costs for participation in the Annual Biomedical Research
Conference for Minority Students to broaden outreach to
underrepresented minorities and foster interest in careers in
computational biology and bioinformatics.
 |